After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KURA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Kura Oncology Inc is $725.62M. A total of 1.28 million shares were traded on the day, compared to an average of 1.62M shares.
In the most recent transaction, WILSON TROY EDWARD bought 50,000 shares of KURA for 8.20 per share on Sep 08 ’25. After the transaction, the President & CEO now owns 100,968 company shares. In a previous transaction on Aug 12 ’25, WILSON TROY EDWARD bought 36,506 shares at 5.85 per share. KURA shares that President and CEO owns now total 37,474.
Among the insiders who bought shares, WILSON TROY EDWARD acquired of 13,494 shares on Aug 13 ’25 at a per-share price of $6.64. This resulted in the President and CEO holding 50,968 shares of KURA after the transaction. In another insider transaction, Bair Teresa Brophy sold 1,559 shares at $5.96 per share on May 19 ’25. Company shares held by the Chief Legal Officer now total 107,948.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KURA has a high of $20.00 and a low of $5.41.
As of this writing, KURA has an earnings estimate of -$0.68 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of $0.49 per share and a lower estimate of -$0.98. The company reported an EPS of -$0.63 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KURA’s latest balance sheet shows that the firm has $517.96M in Cash & Short Term Investments as of fiscal 2021. There were $6.88M in debt and $22.45M in liabilities at the time. Its Book Value Per Share was $3.52, while its Total Shareholder’s Equity was $506.61M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KURA is Buy with a score of 4.53.
